THE BALANCEhttps://thebalance.clinic/resources/medication/xanax-make-you-sleepy/
THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Clinical resource

Does Xanax Make You Sleepy

The connection between Xanax and sleepiness involves understanding its effects on the central nervous system.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

Quick Summary

  • Xanax can cause drowsiness by enhancing GABA activity, which slows central nervous system activity while reducing anxiety and panic symptoms.
  • Sleepiness may vary with dosage, metabolism, age, health, timing, formulation, and concurrent use of alcohol or other central nervous system depressants.
  • Persistent or worsening drowsiness, dose escalation, or withdrawal symptoms warrant medical advice; prescribed doses should never be changed or stopped without professional guidance.

Xanax, also known as Alprazolam, is a medication that belongs to a class of drugs known as benzodiazepines. It is commonly prescribed for the treatment of anxiety and panic disorder in adults. It is not FDA-approved for insomnia. Drowsiness is one of its most frequently reported side effects, raising questions about how this medicine causes such a response and how to keep it under control.

The connection between Xanax and sleepiness involves understanding its effects on the central nervous system. This article will examine the reasons behind Xanax’s sedative effects, accentuating its pharmacological action and its implications in therapeutic and non-medical settings. Understanding these effects is crucial for those using Xanax, whether under medical supervision or otherwise, to maintain personal safety.

Xanax acts as a central nervous system depressant by enhancing the impact of gamma-aminobutyric acid (GABA), a neurotransmitter responsible for calming the brain. The medication works by binding to specific receptors in the brain, increasing GABA’s efficacy at decreasing neural activity. The process can be divided into three categories:

Enhancing GABA Activity

GABA is integral to managing anxiety by blocking excessive neural activity. By binding to the GABA-A receptors, Xanax adds to the overall relaxing effect. As a result, the general brain activity slows down, causing the individual to experience calm.

Targeting Brain Regions

Alprazolam binds to benzodiazepine sites on GABA-A receptors and enhances GABA-mediated inhibition in the brain. This action contributes to both anxiety relief and sedation. Alprazolam may relieve anxiety symptoms, but FDA approval does not mean it is recommended for routine long-term treatment of anxiety or panic attacks.

Rapid Action

Immediate-release alprazolam reaches peak plasma concentrations about one to two hours after an oral dose. Extended-release alprazolam is absorbed more slowly. Plasma concentration does not specify exactly when anxiety relief or drowsiness starts or is strongest.

MedlinePlus [1] lists drowsiness as a side effect of alprazolam. Several factors contribute to the degree of sleepiness caused by Xanax, such as the following:

Dosage and Frequency

  • Higher Dosage: The sedative effects of Xanax are dose-dependent. Higher doses increase GABA activity, causing more significant CNS depression and drowsiness.
  • Frequency of Use: Repeated doses can accumulate until a steady state is reached; the extent depends on the dose, dosing interval, and clearance. Sedation does not necessarily increase continuously, and tolerance to some effects may develop.

Individual Sensitivity and Metabolism

  • Metabolic Rate: The body’s ability to metabolize Alprazolam varies among people. Individuals with slower metabolic rates may experience prolonged drowsiness as the medicine remains active in their system longer.
  • Age and Health Status: Older adults and people with liver impairment may clear alprazolam more slowly. Kidney disease should not be equated with slower liver metabolism; tell the prescriber about either condition.
  • Body Weight: Lower body weight alone does not reliably predict stronger sedation; individual response requires clinical assessment.

Interaction with Other Substances

  • Alcohol: Avoid alcohol while taking Xanax. The combination can cause dangerous sedation and breathing problems, not just increased sleepiness.
  • Other Medications: Other CNS depressants can increase alprazolam-related sedation. Medicines that inhibit its metabolism can increase exposure and adverse effects. Ask the prescriber or pharmacist to review prescription medicines, over-the-counter products, and supplements before starting, stopping, or changing them.

Duration of Action

  • Half-Life of the Drug: The average elimination half-life of immediate-release alprazolam is about 11.2 hours in healthy adults, with substantial variation. Half-life describes a halving of plasma concentration, not the duration of sedation or complete elimination. Residual effects can persist; its metabolites are unlikely to contribute much.
  • Immediate vs. Extended-Release Formulations: Extended-release alprazolam is absorbed more slowly than immediate-release tablets and is prescribed once daily. Both can cause drowsiness; neither formulation guarantees steady alertness or a predictable duration of sedation.

Time of Administration

Timing: The time of day Xanax is taken can influence the extent of drowsiness. The correct timing depends on the prescribed formulation and schedule; do not move doses to bedtime without consulting the prescriber. However, taking it during the day can disrupt everyday activities, causing unintended daytime drowsiness.

Medication Metabolism

Metabolism: Alprazolam is mainly metabolized by the liver enzyme CYP3A4. Medicines that inhibit this pathway can increase alprazolam exposure and adverse effects. [2]

Excessive drowsiness caused by Xanax can lead to several side effects and issues in daily life, including the following:

Cognitive and Motor Function Issues

Excessive sleepiness can significantly decrease alertness and ability to focus, making it difficult to perform tasks that need focus, such as driving or working. Lack of focus can delay reaction times, making it challenging to respond quickly in situations that require rapid decision-making. A randomized crossover study in 20 healthy volunteers found impaired driving, memory, and psychomotor performance after a single 1 mg dose of alprazolam compared with placebo. [3] Impairment is not limited to unusually high doses. Do not drive or operate machinery until you know how alprazolam affects you; never do so while sleepy or impaired.

Elevated Risk of Accidents

The soothing properties of Alprazolam come with a particular risk of accidents while engaging in activities that can be life-threatening without focus. For instance, Xanax use has been associated with higher chances of having car accidents because of slowed reaction times. In older adults or those with mobility issues, excessive sleepiness can increase the risk of falls and associated injuries by negatively impacting balance and coordination.

Increased Effects with Other Substances

The risks of excessive sleepiness and impairments are further increased when Alprazolam is taken with other substances. For example, alcohol [4] can amplify the drug’s depressant effects, increasing drowsiness even more. Similarly, the concurrent use of other central nervous system depressants, such as opioids or sedatives, can lead to severe respiratory depression.

Risk of Overdose

Taking high doses of Xanax, especially without medical supervision, increases the risk of excessive sedation and overdose. Symptoms of overdose include issues in motor function, extreme drowsiness, confusion, and, in severe cases, respiratory depression and coma. Accidental overdose is also a concern when individuals take more doses to manage consistent anxiety without understanding that the residual sedative effects may still be present. An Australian observational study of deliberate self-poisoning admissions documented intensive-care treatment and mechanical ventilation after alprazolam overdose. [5] Suspected overdose requires immediate medical help; do not wait for symptoms to worsen.

Impact on Daily Life

Consistent drowsiness can interfere with everyday activities, affecting an individual’s ability to function at work, participate in social interactions, and maintain the quality of life. These impairments may cause various adverse outcomes, such as loss of employment, strained relationships, and social isolation. Additionally, the cognitive and physical issues resulting from excessive Alprazolam use can worsen existing mental health conditions.

Sleepiness from Alprazolam can interfere with daily activities and increase the risk of many issues. Hence, managing it on time is crucial to limit damage. Treating drowsiness due to Alprazolam requires several steps, including the following:

Managing Sleepiness Through Lifestyle Adjustments

Daily routines may support general well-being, but they do not reverse alprazolam-related impairment. Discuss troublesome drowsiness with the prescriber. General precautions include:

  • Timing of Dosage: Take alprazolam at the prescribed times. Ask the prescriber about troublesome daytime drowsiness; do not move, combine, or skip doses yourself.
  • Physical Activity: Regular exercise may support general well-being, but it does not reverse medication-related impairment. Avoid activities that require balance, coordination, or sustained attention whenever you are drowsy or impaired, not just immediately after a dose.
  • Sleep Routine: Allow adequate time for sleep and keep regular sleep times where possible. A sleep routine does not prevent medication-related sedation.
  • Dietary Considerations: Limit caffeine intake, specifically late in the day, and avoid alcohol, as it can add to Xanax’s drowsiness.

Seeking Medical Advice for Drowsiness Management

Contact the prescriber if drowsiness is persistent or interferes with daily activities. Extreme sleepiness, slow or difficult breathing, or inability to awaken requires immediate emergency help. Medical guidance may include the following:

  • Medication Adjustments: A doctor may suggest altering the dosage, switching to a different medicine, or changing the timing of doses to decrease sleepiness.
  • Alternative Medications: If excessive sleepiness remains, a healthcare provider might suggest an alternative treatment option with a lower risk of sedation.
  • Regular Monitoring: Plan follow-up appointments to evaluate the medication’s effects and make necessary adjustments as needed with time.
  • Safety Precautions: Do not change the dose or stop alprazolam without prescriber guidance. Abrupt stopping or rapid dose reduction after continued use can cause life-threatening withdrawal, including seizures. Any taper should be individualized and monitored.

Drowsiness can occur when starting or restarting alprazolam. No self-care method guarantees alertness. Discuss the prescription and any break in treatment with the prescriber, and consider these precautions:

  • Dose Selection: The prescriber should select the starting dose and any adjustments according to the formulation, response, age, health, and other medicines. Do not increase the dose to get used to the medication.
  • Hydration: Water or electrolyte supplements do not reverse alprazolam sedation. Extreme sleepiness, slow or difficult breathing, or inability to awaken requires emergency help, not a hydration remedy.
  • Morning Activities: A morning routine does not reverse medication-related impairment. Avoid driving and other hazardous activities while drowsy, and exercise only when alert and coordinated.
  • Rest and Persistent Sleepiness: Do not rely on naps to reverse alprazolam impairment or make driving safe. Persistent daytime sleepiness needs prescriber review; extreme sleepiness or difficulty awakening needs emergency assessment.
  • Low-Impact Activities during the Adjustment Phase: In the first few days of starting Alprazolam, plan the daily schedule to include low-impact activities that do not require intense focus or physical coordination. Light reading, organizing, or engaging in easy hobbies can help individuals stay active without requiring a lot of attention. Do not assume that becoming accustomed to the medicine means you are safe to resume hazardous tasks.

Drowsiness is a side effect, not a reliable indicator of physical dependence or addiction. Physical dependence can develop with prescribed use and means withdrawal may occur when the dose is reduced or stopped. Addiction involves impaired control and continued use despite harm; it is distinct from physical dependence.

Persistent Drowsiness and Tolerance

Tolerance means a reduced response to a medicine with repeated use. It can develop to some alprazolam effects, but it is not the same as physical dependence or addiction. Worsening sleepiness at an unchanged dose warrants clinical review rather than a diagnosis of dependence.

Drowsiness Linked to Increased Dosage

Dose escalation may reflect tolerance, changing symptoms, or other factors; it does not by itself establish physical dependence or addiction. Higher doses can increase adverse effects. Never increase the dose yourself; discuss reduced benefit or increased sleepiness with the prescriber.

Sleepiness and Withdrawal Symptoms

After physical dependence develops, missed doses or dose reductions can cause withdrawal, including anxiety and insomnia. These symptoms can overlap with the original condition and require assessment. Do not take extra doses or stop abruptly to test for dependence.

When to Get Help

Seek prescriber review for persistent or worsening drowsiness, reduced benefit, or difficulty controlling use. The clinician can assess adverse effects, interactions, and treatment needs. If reducing or stopping is appropriate, an individualized taper can reduce, but not eliminate, withdrawal risks.

Xanax, while effective for managing anxiety and panic disorders, often comes with drowsiness as a side effect. Though manageable for some, its sedative properties may become problematic, affecting everyday activities and general health. Recognizing the different aspects of drowsiness linked to Alprazolam, whether as an expected side effect or a reason for clinical review, without treating sleepiness as evidence of dependence, is necessary for the safe use of the medicine. Monitoring sleepiness and seeking medical advice when it changes can help identify adverse effects and guide treatment review. Prescriber review can help balance benefits and risks, but self-care cannot guarantee safe alertness or prevent serious adverse effects.

Questions

Frequently Asked Questions

How long does it take for Alprazolam to make you sleepy?
The timing and intensity of sleepiness vary. Immediate-release alprazolam reaches peak plasma concentrations about one to two hours after a dose; extended-release tablets peak later. These timings do not specify when sleepiness starts or is strongest, or when it is safe to drive.
Why does Xanax make me sleepy even at a low dose?
Xanax enhances the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that slows down brain activity, causing a calming and sedative effect. Even at low doses, this action of the drug can lead to drowsiness, specifically in individuals who are more sensitive to the medicine or those using benzodiazepines for the first time. Age, liver function, and other medicines can also influence its effects.
What to do in case of an accidental overdose on Xanax?
If an accidental overdose of Xanax is suspected, get immediate medical attention. Overdose symptoms may include extreme drowsiness, confusion, decreased reflexes, and, in severe cases, respiratory depression and loss of consciousness. Do not self-treat or wait for symptoms to resolve. Contact emergency services immediately and follow their instructions; do not drive yourself to an emergency department. Providing healthcare providers with information about the dosage taken and any other substances involved will help in effective treatment.

Editorial evidence

Evidence & sources

Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.

01MedlinePlus. (n.d.). Alprazolam. National Library of Medicine.
02U.S. Food and Drug Administration. (2023). XANAX and XANAX XR (alprazolam): Prescribing information. Reference ID 5118436.
03Verster, J. C., Volkerts, E. R., & Verbaten, M. N. (2002). Effects of alprazolam on driving ability, memory functioning and psychomotor performance: A randomized, placebo-controlled study. Neuropsychopharmacology, 27(2), 260–269. doi:10.1016/S0893-133X(02)00310-X.
View all 11 sourcesShow fewer sources
04National Institute on Alcohol Abuse and Alcoholism. (n.d.). Alcohol-Medication Interactions: Potentially Dangerous Mixes.
05Isbister, G. K., O’Regan, L., Sibbritt, D., & Whyte, I. M. (2004). Alprazolam is relatively more toxic than other benzodiazepines in overdose. British Journal of Clinical Pharmacology, 58(1), 88–95. doi:10.1111/j.1365-2125.2004.02089.x.
06U.S. Food and Drug Administration. (2020). FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class.View source
07American Society of Addiction Medicine and partner societies. (2025). Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations when Benzodiazepine Risks Outweigh Benefits.
08Substance Abuse and Mental Health Services Administration. (n.d.). Find Substance Use Disorder Treatment. U.S. treatment resources.
10U.S. Food and Drug Administration. (2021). XANAX XR (alprazolam) extended-release tablets: Prescribing information. Revised March 2021.View source
11World Health Organization. (2023). Benzodiazepines in treatment of adults with generalized anxiety disorder and/or panic disorder.
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care